MRE-IA in Liver Disease and Neurovascular Imaging

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Diffuse and Focal Liver Diseases, Cerebral Function
Interventions
OTHER

Stimuli

Visual stimulation while using additional sequencing

OTHER

No stimuli

Additional sequencing only

Trial Locations (2)

H2X0C1

CRCHUM, Montreal

J1H 5N4

CRCHUS, Sherbrooke

All Listed Sponsors
collaborator

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

collaborator

Réseau de bio-imagerie du Québec (RBIQ)

UNKNOWN

lead

Université de Sherbrooke

OTHER

NCT03601845 - MRE-IA in Liver Disease and Neurovascular Imaging | Biotech Hunter | Biotech Hunter